These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20956953)

  • 1. Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated.
    Gottschalk S
    Bone Marrow Transplant; 2011 Jan; 46(1):18-9. PubMed ID: 20956953
    [No Abstract]   [Full Text] [Related]  

  • 2. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic Epstein-Barr virus infection].
    Imashuku S; Teramura T
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():503-7. PubMed ID: 15861702
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.
    Okamura T; Hatsukawa Y; Arai H; Inoue M; Kawa K
    Lancet; 2000 Jul; 356(9225):223-4. PubMed ID: 10963205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection.
    Kawa K; Sawada A; Sato M; Okamura T; Sakata N; Kondo O; Kimoto T; Yamada K; Tokimasa S; Yasui M; Inoue M
    Bone Marrow Transplant; 2011 Jan; 46(1):77-83. PubMed ID: 20498651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease].
    Kawa K
    Rinsho Ketsueki; 2008 Jun; 49(6):390-6. PubMed ID: 18646606
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H
    Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection.
    Fujii N; Takenaka K; Hiraki A; Maeda Y; Ikeda K; Shinagawa K; Ashiba A; Munemasa M; Sunami K; Hiramatsu Y; Ishimaru F; Niiya K; Yoshino T; Harada M
    Bone Marrow Transplant; 2000 Oct; 26(7):805-8. PubMed ID: 11042666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E; Cornelissen JJ
    Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.
    Kimura H; Hoshino Y; Hara S; Sugaya N; Kawada J; Shibata Y; Kojima S; Nagasaka T; Kuzushima K; Morishima T
    J Infect Dis; 2005 Feb; 191(4):531-9. PubMed ID: 15655776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete resolution of severe chronic active Epstein-Barr virus infection by cultured, activated donor T lymphocyte infusion after nonmyeloablative stem cells allografting.
    Yoshiba F; Hagihara M; Tazume K; Ogawa Y; Kishi K; Higuchi A; Kato S; Hotta T
    Bone Marrow Transplant; 2003 Jul; 32(1):107-10. PubMed ID: 12815486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
    Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
    Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EBV-positive T/NK lymphoproliferative disease in childhood].
    Kimura H
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():692-6. PubMed ID: 23134030
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and treatment of chronic active EBV infection].
    Kawa K
    Uirusu; 2002 Dec; 52(2):257-60. PubMed ID: 12685317
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy with virus-specific cytotoxic T lymphocytes after organ transplantation.
    Lucas KG; Sun Q
    Pediatr Transplant; 2006 Mar; 10(2):142-4. PubMed ID: 16573596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease.
    Lucas KG; Salzman D; Garcia A; Sun Q
    Cancer; 2004 May; 100(9):1892-901. PubMed ID: 15112270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic active Epstein-Barr virus infection].
    Kimura H
    Uirusu; 2011 Dec; 61(2):163-73. PubMed ID: 22916563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.